Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulating Alpha-connectivity in Patients with Active Suicidal Ideation Using Transcranial Alternating Current Stimulation

NCT06832124 is registered in ClinicalTrials.gov with Sebastian Olbrich as lead sponsor.

NCT NCT06832124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06832124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulating Alpha-connectivity in Patients with Active Suicidal Ideation Using Transcranial Alternating Current Stimulation
Lead sponsor
Sebastian Olbrich
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 31, 2026
Completion date
December 31, 2026
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

depression disorders, suicidal ideation active